Kenvue asks FDA to not change Tylenol label on potential autism risk

3 hours ago 1
Tylenol Extra Strength for adults box

jfmdesign

Kenvue (NYSE:KVUE) is formally pushing back against efforts to change the labeling of Tylenol (acetaminophen) after the Trump administration in September linked the over-the-counter painkiller to a potential increase in the risk of autism in a child if

Recommended For You

More Trending News

Read Entire Article
  1. Homepage
  2. Finance
  3. Kenvue asks FDA to not change Tylenol label on potential autism risk

Related

W. R. Berkley signals continued rate discipline and capital strength as underwriting cycle shifts

W. R. Berkley signals continued rate discipline and capital ...

8 minutes ago 0
Best Low-Capital Business Ideas in Rural Philippines (2025)

Best Low-Capital Business Ideas in Rural Philippines (2025)

11 minutes ago 0
Oil drifts to new five-month lows on supply glut worries, trade tensions

Oil drifts to new five-month lows on supply glut worries, tr...

12 minutes ago 0
Kinder Morgan, Phillips 66 propose first-ever California-bound fuel pipeline

Kinder Morgan, Phillips 66 propose first-ever California-bou...

50 minutes ago 0
Ascendis Pharma struggles after report of Yorvipath patient death

Ascendis Pharma struggles after report of Yorvipath patient ...

1 hour ago 0
Alcoa to collaborate with U.S., Australia on new gallium plant

Alcoa to collaborate with U.S., Australia on new gallium pla...

1 hour ago 0
Here are the major earnings before the open Tuesday

Here are the major earnings before the open Tuesday

1 hour ago 0
Genentech wins approval of lupus drug obinutuzumab

Genentech wins approval of lupus drug obinutuzumab

1 hour ago 0
Gold price resumes upward march after one-day reprieve as trading volume tops record

Gold price resumes upward march after one-day reprieve as tr...

1 hour ago 0
‘Sad, if not damning’: Cathie Wood blasts the proxy firms who say Elon Musk’s $1 trillion pay package is just too rich

‘Sad, if not damning’: Cathie Wood blasts the proxy firms wh...

1 hour ago 0
Merck starts construction on $3B manufacturing plant in Virginia

Merck starts construction on $3B manufacturing plant in Virg...

1 hour ago 0
East West Bancorp Q3 2025 Earnings Preview

East West Bancorp Q3 2025 Earnings Preview

1 hour ago 0
PennyMac Financial Q3 2025 Earnings Preview

PennyMac Financial Q3 2025 Earnings Preview

1 hour ago 0
Chubb Q3 2025 Earnings Preview

Chubb Q3 2025 Earnings Preview

1 hour ago 0
KORE announces private placement, board change

KORE announces private placement, board change

2 hours ago 0
Cogent gains FDA Breakthrough Therapy status for bezuclastinib

Cogent gains FDA Breakthrough Therapy status for bezuclastin...

2 hours ago 0
Eason Technology receives NYSE American non-compliance letter

Eason Technology receives NYSE American non-compliance lette...

2 hours ago 0
Cleveland-Cliffs outlines multiyear OEM contracts and $425M asset sales while advancing rare earths initiative

Cleveland-Cliffs outlines multiyear OEM contracts and $425M ...

2 hours ago 0
Dynex Capital signals continued portfolio growth and strategic expansion with New York office amid $1.8B market cap milestone

Dynex Capital signals continued portfolio growth and strateg...

2 hours ago 0
Sunoco LP raises dividend by 1.3% to $0.9202

Sunoco LP raises dividend by 1.3% to $0.9202

2 hours ago 0

Trending

1. telugu
2. kolkata
3. nba
4. you
5. blue
6. sec
7. stranger things
8. हिंदी
9. alia bhatt
10. cx

Popular

Gold ETFs see 6-fold jump in September inflows: What's driving surge?

Gold ETFs see 6-fold jump in September inflows: What's ...

5 days ago 7
GoodRx launches subscription program for men's hair loss

GoodRx launches subscription program for men's hair loss

5 days ago 7
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© FBT Company 2025. All rights are reserved